All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F20%3AN0000076" target="_blank" >RIV/00064190:_____/20:N0000076 - isvavai.cz</a>

  • Alternative codes found

    RIV/00669806:_____/21:10414938 RIV/00064190:_____/21:N0000146 RIV/00216208:11110/21:10414938 RIV/00216208:11140/21:10414938

  • Result on the web

    <a href="http://dx.doi.org/10.1038/s41371-020-0327-3" target="_blank" >http://dx.doi.org/10.1038/s41371-020-0327-3</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41371-020-0327-3" target="_blank" >10.1038/s41371-020-0327-3</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?

  • Original language description

    Advanced glycation end products (AGEs) are involved in several pathophysiologic processes in vascular diseases, including progressive loss of elasticity of the vessel wall (arterial stiffness). Circulating soluble receptors for AGEs (sRAGE) act as a decoy and counterbalanced the harmful properties of AGEs as the natural protective factor. We compared the role of circulating or skin-deposed AGEs and sRAGE regarding the natural course of arterial stiffening. In a prospective cohort study, we longitudinally followed 536 general population-based subjects (subsample of Czech post-MONICA study). Aortic pulse-wave velocity (PWV) was measured twice (at baseline and after 8 years of follow-up) using a SphygmoCor device (AtCor Medical Ltd), and the intraindividual change in PWV per year ( increment PWV/year) was calculated. Concentrations of sRAGE and carboxymethyl lysine (circulating AGEs) were assessed at the follow-up visit by ELISA, while skin AGEs were measured using the autofluorescence-based device AGE Reader. Using multiple regressions, we found significant association between increment PWV/year as a dependent variable, and both, sRAGE and skin AGEs as independent ones (each on its own model). However, the closest associations to increment PWV/year were found for the ratio of these two factors (skin AGEs/sRAGE) [beta coeff = 0.0747 (SE 0.0189), p < 0.0001]. In a categorized manner, subjects with skin AGEs/sRAGE ratio >= 3.3 showed about twofold higher risk having Delta PWV/year >= 0.2 m/s [adjusted odds ratio was 2.09 (95% CI: 1.35-3.22), p = 0.001]. In contrast, neither circulating AGEs nor circulating AGEs/sRAGE showed any significant relation to Delta PWV/year. In conclusion, skin AGEs/sRAGE ratio seems to be a more sensitive biomarker of vascular aging than these single factors themselves or circulation status of AGEs.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30201 - Cardiac and Cardiovascular systems

Result continuities

  • Project

    <a href="/en/project/NV15-27109A" target="_blank" >NV15-27109A: Longitudinal trends in major cardiovascular risk factors and their predictive value in a population random sample, Czech post-MONICA study</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2020

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    JOURNAL OF HUMAN HYPERTENSION

  • ISSN

    0950-9240

  • e-ISSN

    1476-5527

  • Volume of the periodical

    35

  • Issue of the periodical within the volume

    3

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    10

  • Pages from-to

    240-249

  • UT code for WoS article

    000519421900002

  • EID of the result in the Scopus database

    2-s2.0-85082188266